UnknownNot Applicable

Vasopressor Support, Mean Arterial Pressure and Capillary Refill Time in Critically Ill Patients

Poland150 participantsStarted 2022-12-03

Plain-language summary

The goal of this observational study is to learn whether different doses of various vasopressor drugs influence capillary refill time (CRT) value in crtically ill patients. The main questions it aims to answer are: * How do vasopressor drugs determine CRT value * How does mean arterial pressure (MAP) determine CRT value * How often CRT value is normal (\< 3 sec) despite hypotensive MAP (\<65 mmHg) Participants will have the CRT measured over the course of the ICU hospitalization. At the end of the study, multiple linear regression will be performed to verify whether different doses of vasopressor drugs influence CRT value.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * critical illness requiring vasopressor support * invasive blood pressure monitoring Exclusion Criteria: * finger distal phalanx not available * patient in a room of suboptimal ambient temperature

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Effect of norepinephrine dose on CRT value

Timeframe: Through study completion, an average of 1 year

Effect of mean arterial pressure on CRT value

Timeframe: Through study completion, an average of 1 year

Trial details

NCT IDNCT05674084

SponsorMedical University of Silesia

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-10-31

Contact for this trial

Zbigniew Putowski, Dr

+48 32 789 42 01 putowski.zbigniew@gmail.com

View on ClinicalTrials.gov More Critical Illness trials